ESAB Corporation announced R. Brent Jones has been appointed Chief Financial Officer, effective early May 2026. Mr. Jones succeeds Kevin Johnson, who is leaving ESAB to pursue a CFO opportunity at a privately held company. Kevin will support ESAB in facilitating a smooth transition.
Mr. Jones, age 56, has served as Executive Vice President and Chief Financial Officer of Avantor Inc., a life sciences solutions provider, since August 2023. Previously, Mr. Jones was Executive Vice President, Chief Financial Officer and Chief Operating Officer at LifeScan Global Corporation, a medical devices company, from March 2023 to July 2023 and Chief Financial Officer at LifeScan from February 2020 to March 2023. Earlier in his career, Mr. Jones served as Chief Financial Officer at Klöckner Pentaplast Group, a global packaging products manufacturer, from April 2016 to August 2018.
He also held the role of interim Chief Financial Officer at Pall Corporation, where he led the company's $13.8 billion sale to Danaher in 2015. Mr. Jones began his career in investment banking with firms including Merrill Lynch and Bank of America, and practiced corporate law at Cravath, Swaine & Moore. He holds an A.B. in Biochemistry and Asian Studies from Dartmouth College and a J.D. from Yale Law School.
On March 30, 2026, Kevin Johnson, Executive Vice President and Chief Financial Officer of the Company, submitted his resignation to pursue a CFO opportunity at a privately held company. Mr. Johnson will support ESAB in facilitating a smooth transition. Mr. Johnson?s decision to resign was due to personal reasons and was not a result of any disagreement with the Company on any matter relating to the Company?s financial statements, internal control over financial reporting, operations, policies or practices.
Mr. Johnson?s last day of employment with the Company is expected to be on or about March 31, 2026. Shyam Kambeyanda, the Company?s President and Chief Executive Officer, will act as interim principal financial officer until Mr. Jones joins the Company.

















